US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

20.18

-0.3280-1.60%

Post-market: 20.180.00000.00%16:10 EST

Volume:6.18K

Turnover:124.69K

Market Cap:3.23M

PE:- -

High:20.50

Open:20.50

Low:20.00

Close:20.50

52wk High:53.37

52wk Low:20.00

Shares:160.00K

Float Shares:60.00K

Volume Ratio:1.06

T/O Rate:10.30%

Dividend:0.65

Dividend Rate:3.24%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

FDA Approves Novo Nordisk's Growth Disorder Treatment For New Populations

FDA approves Novo Nordisk’s Sogroya for three additional pediatric indications

Novo Nordisk’s CagriSema Trial Update: What Investors Should Watch in the GLP‑1 Race

Novo Nordisk (0QIU) Receives a Hold from Barclays

Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2

Benzinga_recent_news

Novo Nordisk A/S Stock Rises Thursday, Outperforms Market

Novo Nordisk on Track for Lowest Close Since May 2021 -- Data Talk

For the first time in decades, new hair-loss treatments are in the works. Here's how they're different.

Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment

Benzinga_recent_news

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live

Ozempic Price War - Novo Nordisk Slashes Prices By 50%

Novo Nordisk, Vivtex Collaborate on Oral Biologics for Obesity, Diabetes

MT Newswires Live

Novo Nordisk Invests Up to $2.1 Billion in Partnership with Vivtex to Advance Next-Generation Oral Weight-Loss Therapies

NYSE Most Active Issues

Novo Nordisk price target lowered to DKK 270 from DKK 340 at Barclays

Novo Nordisk A/S Stock Falls Tuesday, Underperforms Market

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

MT Newswires Live

BofA sees limited impact to Eli Lilly’s franchise from Novo’s GLP-1 price update

Eli Lilly Shares Dip Over 1.5% in Premarket Trading Following Rival Novo Nordisk's GLP-1 Drug Price Reduction Announcement

Novo Nordisk Stock (NVO) Sinks Further on Wegovy and Ozempic Price-Cut Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVOH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":20.176,"timestamp":1772226000000,"preClose":20.504,"halted":0,"volume":6179,"hourTrading":{"tag":"盘后","latestPrice":20.176,"preClose":20.176,"latestTime":"16:10 EST","volume":6,"amount":121.056,"timestamp":1772226603892,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.015996878657823007,"floatShares":60000,"shares":160000,"eps":0,"marketStatus":"Market Closed","change":-0.328,"latestTime":"02-27 16:00:00 EST","open":20.5,"high":20.5,"low":20,"amount":124687.3164,"amplitude":0.024385,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":20.504,"dividendRate":0.03244,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":20.41,"preClose":20.504,"latestTime":"08:00 EST","volume":45,"amount":920.55195,"timestamp":1772197203455,"change":-0.094,"changeRate":-0.004584,"amplitude":0.003902},"postHourTrading":{"tag":"盘后","latestPrice":20.176,"preClose":20.176,"latestTime":"16:10 EST","volume":6,"amount":121.056,"timestamp":1772226603892,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.061501},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":60000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.061501,"shares":160000,"dividePrice":0.6545,"high":20.5,"amplitude":0.024385,"preClose":20.504,"low":20,"week52Low":20,"pbRate":"--","week52High":53.3695,"institutionHeld":0,"latestPrice":20.176,"eps":0,"divideRate":0.03244,"volume":6179,"delay":0,"ttmEps":0,"open":20.5,"prevYearClose":27.4362,"prevWeekClose":25.44,"prevMonthClose":31.55,"prevQuarterClose":27.4362,"fiveDayClose":25.44,"twentyDayClose":31.2381,"sixtyDayClose":26.7923},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614862276","title":"FDA Approves Novo Nordisk's Growth Disorder Treatment For New Populations","url":"https://stock-news.laohu8.com/highlight/detail?id=2614862276","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614862276?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:18","pubTimestamp":1772227080,"startTime":"0","endTime":"0","summary":"Novo Nordisk received approval from the Food and Drug Administration for three new indications of Sogroya, a growth hormone.Sogroya is now indicated for kids aged 2.5 years and older with disorders affecting their height, including idiopathic short stature, short stature born small for gestational age, or growth failure associated with Noonan Syndrome.It is also indicated for children of the same age group and adults with growth hormone deficiency.Sogroya is a once-weekly injection which comes in 5 mg, 10 mg and 15 mg dosages.Novo Nordisk has been studying Sogroya as a way for people with growth disorders to avoid daily injections. In a study, Sogroya demonstrated non-inferiority compared with daily somatropin and growth hormone dosages.Novo Nordisk also submitted a supplemental application for Sogroya's approval in the U.S. for Turner Syndrome. A decision is expected later this year, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FDA Approves Novo Nordisk's Growth Disorder Treatment For New Populations","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","BK4588","NVOX","LU1093756325.SGD","BK4007","BK4532","BK4599","BK4585","IE00BKVL7J92.USD","LU0154236417.USD","NVO","IE00BZ1G4Q59.USD","NVOH"],"gpt_icon":1},{"id":"2614862598","title":"FDA approves Novo Nordisk’s Sogroya for three additional pediatric indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2614862598","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614862598?lang=en_us&edition=fundamental","pubTime":"2026-02-28 04:55","pubTimestamp":1772225721,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced that the US Food and Drug Administration has approved three new indications for once-weekly Sogroya injection 5 mg, 10...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-novo-nordisks-sogroya-for-three-additional-pediatric-indications-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-novo-nordisks-sogroya-for-three-additional-pediatric-indications-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVOH","LU1093756168.USD","BK4599","NVO","NVOX","BK4588","LU0154236417.USD","BK4585"],"gpt_icon":0},{"id":"2614863958","title":"Novo Nordisk’s CagriSema Trial Update: What Investors Should Watch in the GLP‑1 Race","url":"https://stock-news.laohu8.com/highlight/detail?id=2614863958","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614863958?lang=en_us&edition=fundamental","pubTime":"2026-02-28 00:33","pubTimestamp":1772210036,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk A/S (NVO) is running a study called “Effect of CagriSema, Sem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-cagrisema-trial-update-what-investors-should-watch-in-the-glp‑1-race?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-cagrisema-trial-update-what-investors-should-watch-in-the-glp‑1-race?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4590","BK4585","NVOX","LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","BK4532","IE00BKVL7J92.USD","BK4599","BK4211","LU1093756325.SGD","NVO","BK4144","LU1093756168.USD","BK4588","NVOH"],"gpt_icon":0},{"id":"2614859659","title":"Novo Nordisk (0QIU) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2614859659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614859659?lang=en_us&edition=fundamental","pubTime":"2026-02-27 21:36","pubTimestamp":1772199410,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Hold rating on Novo Nordisk today and set a price target of DKK270.00. According to TipRanks, Gordon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","CFA","BK4588","LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH","BK4007","BK4599","NVOX"],"gpt_icon":0},{"id":"2614802799","title":"Eli Lilly's New Oral Weight Loss Drug Outperforms Semaglutide, Eyes Potential US Approval In Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2614802799","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614802799?lang=en_us&edition=fundamental","pubTime":"2026-02-27 01:59","pubTimestamp":1772128740,"startTime":"0","endTime":"0","summary":"Eli Lilly shares rise after orforglipron beats Novo's drug in Phase 3, cutting A1C by 2.2% and boosting weight loss results.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/26/Eli-Lilly.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/26/Eli-Lilly.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/02/50900949/eli-lillys-new-oral-weight-loss-drug-outperforms-semaglutide-eyes-potential-us-approval-in-q2","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/02/50900949/eli-lillys-new-oral-weight-loss-drug-outperforms-semaglutide-eyes-potential-us-approval-in-q2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0154236417.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU2552382132.HKD","LU2491050154.USD","LU2750360641.GBP","LU2896262040.SGD","LU1023059063.AUD","LU1069344957.HKD","LU2237443978.SGD","BK4581","LU2063271972.USD","LU0320765992.SGD","LU0787776722.HKD","IE00BJJMRY28.SGD","LU0234572021.USD","IE00B4R5TH58.HKD","LU0820562030.AUD","LU1868837300.USD","LU0061475181.USD","LU1989771016.USD","LU2552382215.SGD","SG9999014880.SGD","IE0004445015.USD","LU0203202063.USD","LU0323591593.USD","LU1232071149.USD","LU1551013425.SGD","IE0001KFT4U8.USD","LLY","LU2602419157.SGD","LLYX","BK4217","LU2417539215.USD","LU0094547139.USD","LU2746668974.SGD","IE00B1BXHZ80.USD","LU2552382058.USD","IE00BN29S564.USD","LU0353189680.USD","LU0266013472.USD","LU2089283258.USD","LU2491049909.HKD","LU0097036916.USD","LU1035775433.USD","LU0109391861.USD","SG9999018865.SGD","LU0096364046.USD","LU0158827781.USD","LU2271345857.HKD","IE00BFTCPJ56.SGD","LU0122379950.USD","SGXZ57979304.SGD","LU2756315664.SGD","SG9999015945.SGD","SG9999001176.USD","LU1868836757.USD","SG9999001176.SGD","SG9999014914.USD","LU0210536198.USD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU0320765059.SGD","LU0158827948.USD","LU1093756325.SGD","LU1868837136.USD","LU1551013342.USD","LU2237443622.USD","LU1804176565.USD","LU0672654240.SGD","LU2360106947.USD","LU2750360997.AUD","LU1280957306.USD","IE00BK4W5M84.HKD","LU1868836591.USD","LU1267930730.SGD","LU1366192091.USD","LU2361044949.HKD","LU2756315318.SGD","LU1057294990.SGD","LU1291159041.SGD","LU0385154629.USD","LU2213496289.HKD","IE00BZ1G4Q59.USD","IE00BFSS7M15.SGD","LU0109394709.USD","LU0466842654.USD","IE0005OL40V9.USD","LU1629891620.HKD","LU2236285917.USD","LU2237443549.SGD","LU0225283273.USD","LU0683600562.USD","LU1974910355.USD","LU0238689110.USD","LU2361045086.USD","IE00BKPKM429.USD","LU2023251221.USD","LU2456880835.USD","IE00B775H168.HKD","LU0786609619.USD","IE00BK4W5L77.USD","LU2168564149.EUR","LU0256863902.USD","LU0114720955.EUR","LU0058720904.USD","LU2361044865.SGD","IE00BKDWB100.SGD","LU2471134796.USD","IE00BKVL7J92.USD","SG9999018857.SGD","BK4533","LU2471134523.USD","LU0256863811.USD","NVOH","LU0203201768.USD","SG9999017495.SGD","SGXZ31699556.SGD","SG9999015952.SGD","LU0882574055.USD","LU2023250504.SGD","ELIS","LU2237443895.HKD","LU2265009873.SGD","LU2462157665.USD","LU1720051108.HKD","LU0964807845.USD","LU0823416689.USD","SG9999013999.USD","SGXZ81514606.USD","LU1712237335.SGD","LU0006306889.USD","IE00BWXC8680.SGD","LU2168564065.EUR","SG9999015986.USD","SG9999014898.SGD","LU1720051017.SGD","LU0354030511.USD","LU2468319806.SGD","SGXZ99366536.SGD","IE00B4JS1V06.HKD","LU2089984988.USD","LU2111349929.HKD","BK4585","LU0471298777.SGD","LU1548497426.USD","LLYZ","LU0820561909.HKD","LU0823434740.USD","LU2324357040.USD","LU1623119135.USD","BK4588","BK4007","LU2461242641.AUD","LU2237443465.HKD","LU2168564222.USD","LU0353189763.USD","LU1093756168.USD","LU1145028129.USD","IE00BJLML261.HKD","LU0708995401.HKD","LU2237438978.USD","IE0009355771.USD","LU2087625088.SGD","ELIL","IE0002141913.USD","IE00BJT1NW94.SGD","LU0417517546.SGD","LU2112291526.USD","LU2168564495.EUR","NVOX","LU0689472784.USD","LU1127390331.HKD","LU2108987350.USD","LU1814569148.SGD","LU1868836914.USD","LU2237443382.USD","IE0004445239.USD","LU2471134952.CNY","GB00BDT5M118.USD","LU0354030438.USD","LU2357305700.SGD","LU2023250330.USD","LU2089284900.SGD","LU0198837287.USD","BK4599","LU1917777945.USD","LU1988902786.USD","LU0079474960.USD","LU2106854487.HKD","LU1323610961.USD","BK4534","LU0106261372.USD","LU2746668461.USD","LU2471134879.HKD","LU0432979614.USD","LU0823434583.USD","LU2491050071.SGD","LU0882574139.USD","SGXZ51526630.SGD","LU1064131342.USD","LU1983299246.USD","LU0289739699.SGD","LU2168563687.JPY","LU0471298694.HKD","LU1061106388.HKD","IE00BFSS8Q28.SGD","IE00BJJMRX11.SGD","BK4516","LLII","LU0316494557.USD","LU2264538146.SGD","SG9999014906.USD","LU0820561818.USD","LU2211815571.USD","LU2028103732.USD","IE00B7KXQ091.USD","LU0943347566.SGD","SG9999015978.USD","IE00B1XK9C88.USD","LU0640476718.USD","BK4532"],"gpt_icon":1},{"id":"2614021223","title":"Novo Nordisk A/S Stock Rises Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2614021223","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614021223?lang=en_us&edition=fundamental","pubTime":"2026-02-27 01:02","pubTimestamp":1772125320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S advanced 0.1% to DKK238.60 Thursday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.1% to 2,601.46.The stock's rise  snapped a five-day losing streak.The company closed DKK412.60 below its 52-week high of DKK651.20, which the company achieved on March 3, 2025.Trading volume was 9,819,212, compared to the 50-day average trading volume of 9,068,420.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novo Nordisk A/S Stock Rises Thursday, Outperforms Market","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","BK4007","IE00BKVL7J92.USD","NVOX","NVO","LU1093756325.SGD","LU0154236417.USD","BK4588","IE00BZ1G4Q59.USD","BK4599","LU1093756168.USD","BK4585","BK4532"],"gpt_icon":1},{"id":"2614902134","title":"Novo Nordisk on Track for Lowest Close Since May 2021 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2614902134","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614902134?lang=en_us&edition=fundamental","pubTime":"2026-02-27 00:42","pubTimestamp":1772124120,"startTime":"0","endTime":"0","summary":"Novo Nordisk A/S Sponsored ADR Class B  is currently at $37.74, down $0.42 or 1.11%. --Would be lowest close since May 6, 2021, when it closed at $37.10. --On pace for largest percent decrease since Feb. 25, 2026, when it fell 1.11%. --Currently down eight consecutive days; down 23.88% over this period. --Longest losing streak since Nov. 4, 2025, when it fell for 11 straight trading days. --Down 36.51% month-to-date; on pace for worst month on record . --Down 74.31% from its all-time closing high of $146.91 on June 25, 2024. --Down 57.71% from 52 weeks ago , when it closed at $89.22. --Down 58.47% from its 52-week closing high of $90.86 on March 5, 2025. --Traded as low as $37.33; lowest intraday level since May 6, 2021, when it hit $36.76","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","BK4007","BK4588","BK4585","BK4599","LU1093756325.SGD","NVO","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVOX","LU0154236417.USD"],"gpt_icon":1},{"id":"2614053785","title":"For the first time in decades, new hair-loss treatments are in the works. Here's how they're different.","url":"https://stock-news.laohu8.com/highlight/detail?id=2614053785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614053785?lang=en_us&edition=fundamental","pubTime":"2026-02-26 04:36","pubTimestamp":1772051760,"startTime":"0","endTime":"0","summary":"'Botox on steroids': Old hair-loss drugs are getting an upgrade, and new ones are on the way. People experiencing hair loss have had few treatment options.People who are losing their hair face a frustrating struggle to stop or reverse it.They can book a flight to Turkey for a hair transplant, spend hundreds of dollars on unproven remedies advertised online, or take one of only two medications that have actually been shown to work: minoxidil and finasteride.\"It's been decades since we've had a new treatment,\" said George Cotsarelis, chair of dermatology at the University of Pennsylvania Perelman School of Medicine in Philadelphia. \"The suspense has been building and building, and now we have a few things that are either a variation on minoxidil or maybe something new, but they're still very, very early.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","LU0061475181.USD","LU0882574055.USD","LU0471298694.HKD","IE00B775H168.HKD","LU2023250504.SGD","LU2417539215.USD","LU2552382132.HKD","LU2168564495.EUR","LU1974910355.USD","LU1267930730.SGD","LU1868836914.USD","IE00B4JS1V06.HKD","LU0672654240.SGD","LU1057294990.SGD","LU1917777945.USD","LU2491049909.HKD","BK4007","SGXZ99366536.SGD","LU0265550359.USD","LU1988902786.USD","BK4550","BK4533","LU2462157665.USD","IE00BFSS7M15.SGD","BK4559","IE00BK4W5L77.USD","LU2111349929.HKD","BK4581","LU1868837136.USD","LU2471134952.CNY","SG9999013999.USD","SG9999014880.SGD","LU0122379950.USD","LU0203202063.USD","LU2108987350.USD","IE00BKPKM429.USD","LU0456855351.SGD","LU1868837300.USD","LU2168564065.EUR","LU2023250330.USD","LU0234572021.USD","LU0353189680.USD","LU1064131342.USD","LU1069344957.HKD","LU1162221912.USD","IE000M9KFDE8.USD","LU0154236417.USD","LU0965509101.SGD","BK4532","LU1989772840.SGD","LU2125154935.USD","IE00BWXC8680.SGD","LU2237443465.HKD","LU0130517989.USD","LU0316494557.USD","LU0823434740.USD","LU1548497426.USD","LU2360032135.SGD","SG9999015952.SGD","BK4585","LU1699723380.USD","IE00B7KXQ091.USD","LU2896262040.SGD","LU0323591593.USD","LU0820562030.AUD","LU1035775433.USD","LU1037948541.HKD","LU1093756325.SGD","LU1066051498.USD","IE0004445239.USD","IE00B1BXHZ80.USD","LU0861579265.USD","LU1061106388.HKD","LU1720051108.HKD","LU2213496289.HKD","ELIS","LU2063271972.USD","LU0114720955.EUR","LU0070302665.USD","SG9999015986.USD","LU0889565916.HKD","LU0985320562.USD","IE0001KFT4U8.USD","LU0079474960.USD","IE00BBT3K403.USD","LU2357305700.SGD","LU0417517546.SGD","BK4599","IE00BSNM7G36.USD","LU0320765646.SGD","LU1023059063.AUD","LU2456880835.USD","LU0096364046.USD","LU0640476718.USD","GB00BDT5M118.USD","LU0820561909.HKD","LU2028103732.USD","LU2236285917.USD","LU1571399168.USD","LU2237438978.USD","SG9999014898.SGD","LU0225283273.USD","LU0208291251.USD","LU0320765992.SGD","LU2211815571.USD","SG9999001176.USD","LU1551013425.SGD","BK4588","BK4516","LLYX","SG9999018865.SGD","IE0004445015.USD","LU0354030511.USD","IE00BJLML261.HKD","LU0689472784.USD","LU1280957306.USD","LU2168564149.EUR","LU2468319806.SGD","LU1291159041.SGD","IE0002141913.USD","LU2106854487.HKD","LU1066051225.USD","LU1066051811.HKD","SG9999014906.USD","LU0203345920.USD","SG9999015978.USD","LU1623119135.USD","ELIL","IE00BKVL7J92.USD","LLYZ","SG9999015945.SGD","LU0098860793.USD","SG9999015341.SGD","LU0006306889.USD","LU2491050071.SGD","LU0964807845.USD","LU0203201768.USD","MANE","SGXZ57979304.SGD","LU0266013472.USD","SG9999002224.SGD","LU1929549753.HKD","LU2089984988.USD","LU2361045086.USD","SG9999014575.USD","IE00BLSP4452.SGD","LU2471134879.HKD","LU2023250843.SGD","SG9999015358.SGD","SG9999018857.SGD","LU2461242641.AUD","LU1934455277.USD","LU2756315664.SGD","LU2491050154.USD","LU0289739699.SGD","LU0354030438.USD","LU2237443622.USD","IE00BFTCPJ56.SGD","IE00BN8TJ469.HKD","LU0965509283.SGD","LU2237443382.USD","LU2746668974.SGD","LU1983299246.USD","LU0683600562.USD","LU2237443978.SGD","LU1116320901.HKD","LU0130102774.USD","LU0943347566.SGD","SG9999014559.SGD","LU2361044865.SGD","LU2264538146.SGD","IE00BFSS8Q28.SGD","LU1066053197.SGD","LU0648001328.SGD","LU2361044949.HKD","LU0823434583.USD","LU0097036916.USD","LU2089283258.USD","LU2087625088.SGD","LU0058720904.USD","IE00BJJMRX11.SGD","LU1201861249.SGD","LU1232071149.USD","LU1430594728.SGD","LU2552382058.USD","LU1868836757.USD","LU2756315318.SGD","LU1323610961.USD","LU1585245621.USD","LU0265550946.USD","LU1720051017.SGD","SGXZ81514606.USD","LU0158827948.USD","IE00B2B36J28.USD","LU2746668461.USD","LU0210536198.USD","LU2360106947.USD","LU1712237335.SGD","LU0158827781.USD","SG9999014542.SGD","LU0256863902.USD","LU2265009873.SGD","LU1116320737.USD","LU2112291526.USD","LU2125154778.USD","LU2237443895.HKD","LU1989771016.USD","LU1037948897.HKD","LU2471134796.USD","LU1941712348.USD","LU2471134523.USD","LU1069347547.HKD","LU0787776722.HKD","LU1814569148.SGD","LU0109391861.USD","LU0211331839.USD","LU0238689110.USD","LU0882574139.USD","SGXZ31699556.SGD","IE00BK4W5M84.HKD","IE00BLSP4239.USD","LU2237443549.SGD","IE00BJJMRZ35.SGD","LU0477156953.USD","LU0466842654.USD","LU0106261372.USD","IE00BN29S564.USD","LU1934455194.USD","LU2324357040.USD","LLII","LU2023251221.USD","LU2552382215.SGD","LU0353189763.USD","LU0708995401.HKD","LU1868836591.USD","IE0005OL40V9.USD","LU0823416689.USD","IE00BKDWB100.SGD","LU2168563687.JPY","NVOH","LU0471298777.SGD","IE00BZ1G4Q59.USD","LU0980610538.SGD","LU1145028129.USD","SG9999017495.SGD","IE00B4R5TH58.HKD","LU0786609619.USD","LU1093756168.USD","LU1941712264.USD","LU2168564222.USD","LU0109394709.USD","LU1989772923.USD","IE00BJT1NW94.SGD","LU2602419157.SGD","IE0009355771.USD","LU0094547139.USD","LU0256863811.USD","LU0820561818.USD","LU2271345857.HKD","SG9999001176.SGD","NVOX","LU0320765489.SGD","BK4534","LU1035773651.USD","LU1366192091.USD","LU0965508806.USD","LU1629891620.HKD","LU0198837287.USD","LU1127390331.HKD","IE00BJJMRY28.SGD","LU2750360641.GBP","SG9999001440.SGD","LU1551013342.USD","SG9999002232.USD","LU0385154629.USD","LU0203347892.USD","LU1934455863.HKD","LU0432979614.USD","LU0320765059.SGD","LU2750360997.AUD","SG9999014567.USD","SG9999014914.USD","SGXZ51526630.SGD","LU1804176565.USD","IE00B1XK9C88.USD","LU2089284900.SGD","MRK"],"gpt_icon":0},{"id":"2614310650","title":"Novo Nordisk's 40% Fall May Be Creating A Deep-Value Moment","url":"https://stock-news.laohu8.com/highlight/detail?id=2614310650","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614310650?lang=en_us&edition=fundamental","pubTime":"2026-02-26 00:33","pubTimestamp":1772037180,"startTime":"0","endTime":"0","summary":"Novo Nordisk now trades at just 10.6x earnings after a 58% crash, far below Eli Lilly, Vertex, and Pfizer — signaling a valuation reset.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Konskie--Poland---January-11--2024-Novo-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Konskie--Poland---January-11--2024-Novo-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50857026/novo-nordisks-40-fall-may-be-creating-a-deep-value-moment","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50857026/novo-nordisks-40-fall-may-be-creating-a-deep-value-moment","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","BK4532","LU0154236417.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4599","BK4585","BK4588","NVOH","NVO","LU1093756168.USD","NVOX"],"gpt_icon":1},{"id":"2614156031","title":"European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2614156031","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614156031?lang=en_us&edition=fundamental","pubTime":"2026-02-26 00:16","pubTimestamp":1772036179,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 1% to 1,860.69 on the S&P Europe Select ADR Index.From continental Europe, the ga","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","00005","BK4521","LU0124676726.USD","LU0154236417.USD","LU2236285917.USD","BK4183","NVOX","BK7104","LU0052756011.USD","LU0300736062.USD","BK4585","BK7511","IE00BKVL7J92.USD","BK4505","SAN","UN","BK4117","BK7142","BK4599","LU1093756168.USD","BK4141","LU1093756325.SGD","NVOH","LU0300736492.USD","BK4158","BK7095","DEO","BK4559","BK4168","LU1267930227.SGD","BK4532","UL","MREO","EVAX","SQNS","BUD","DBVT","LU0689626769.HKD","BHP","BK4169","BK4207","IE00BZ1G4Q59.USD","BK4588","LU0310800965.SGD","BK7119","AMRN","AUTL","BK4007","ULVR.UK","TRIB","BK4142","DGE.UK","BK4592","HSBH","IHG","HSBC","BK7507","CLLS","LU0128525689.USD","BK4107","BK4139"],"gpt_icon":1},{"id":"2614333650","title":"Ozempic Price War - Novo Nordisk Slashes Prices By 50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614333650","media":"Benzinga","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614333650?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:13","pubTimestamp":1772028780,"startTime":"0","endTime":"0","summary":"Novo Nordisk plans up to 50% U.S. price cuts on Wegovy, Ozempic, and Rybelsus by 2027, sending shares lower in premarket trade.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Valparaiso--In-Usa-December-13--2023-Oze.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Valparaiso--In-Usa-December-13--2023-Oze.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/02/50849052/ozempic-price-war-novo-nordisk-slashes-prices-by-50","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/02/50849052/ozempic-price-war-novo-nordisk-slashes-prices-by-50","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU0683600562.USD","IE00BJJMRX11.SGD","LU0238689110.USD","LU1069344957.HKD","LU2089984988.USD","LU1093756325.SGD","BK4532","LU0203201768.USD","LU0882574139.USD","SG9999018865.SGD","LU0353189680.USD","LU1280957306.USD","LU0471298777.SGD","LU0882574055.USD","LU2491049909.HKD","IE00B1XK9C88.USD","LU0058720904.USD","LU2461242641.AUD","LU0823434740.USD","LU2264538146.SGD","GB00BDT5M118.USD","LU2750360997.AUD","IE00B4JS1V06.HKD","LU1868836757.USD","LU2237443549.SGD","LU2087625088.SGD","LU2471134952.CNY","LU0320765059.SGD","IE00BFSS8Q28.SGD","BK4516","LU0316494557.USD","SG9999017495.SGD","LU0094547139.USD","LU2211815571.USD","ELIS","NVO","LU0061475181.USD","IE00BZ1G4Q59.USD","LU0158827781.USD","LU0466842654.USD","LU2237443622.USD","SG9999015952.SGD","LU0820561818.USD","SG9999015986.USD","LU1061106388.HKD","LU2237443978.SGD","LU1145028129.USD","LU2265009873.SGD","LU2468319806.SGD","LU2471134796.USD","LU0786609619.USD","LU0109394709.USD","LLYX","IE0001KFT4U8.USD","LU0385154629.USD","LU0158827948.USD","LU2236285917.USD","LU0354030438.USD","IE00BWXC8680.SGD","IE0005OL40V9.USD","LU2602419157.SGD","BK4585","LU2023250330.USD","IE00BJJMRY28.SGD","LU2023251221.USD","LU2491050154.USD","LU2361045086.USD","LU0097036916.USD","LU0006306889.USD","LU2111349929.HKD","LU2756315318.SGD","NVOX","LU1323610961.USD","SG9999018857.SGD","BK4007","IE00B4R5TH58.HKD","LU2456880835.USD","LU1551013342.USD","LU2746668974.SGD","LU0114720955.EUR","LU2063271972.USD","LU0109391861.USD","LU1551013425.SGD","LU1623119135.USD","LU2746668461.USD","SG9999014914.USD","LU0354030511.USD","LU1974910355.USD","SGXZ31699556.SGD","LU0096364046.USD","LU2471134879.HKD","LU1868837300.USD","IE00BK4W5L77.USD","LU0256863902.USD","LU1127390331.HKD","LU1366192091.USD","LU1868836914.USD","IE00BKVL7J92.USD","SG9999015945.SGD","LU2756315664.SGD","LU2106854487.HKD","LU2089283258.USD","IE00BFSS7M15.SGD","LU0823434583.USD","LU1548497426.USD","LU2237438978.USD","IE00B7KXQ091.USD","LU0106261372.USD","SGXZ51526630.SGD","LU2750360641.GBP","LU0471298694.HKD","LU2491050071.SGD","LU1629891620.HKD","LLYZ","LU0323591593.USD","IE0004445015.USD","LU2462157665.USD","LU1720051017.SGD","SG9999015978.USD","LU0943347566.SGD","LU0198837287.USD","LU0820562030.AUD","LU2237443895.HKD","LU1035775433.USD","SG9999013999.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2324357040.USD","SGXZ99366536.SGD","BK4588","LU0417517546.SGD","IE0002141913.USD","LU1804176565.USD","SG9999014880.SGD","LU1023059063.AUD","LU1983299246.USD","LU2896262040.SGD","IE0009355771.USD","LU0154236417.USD","LU1064131342.USD","LU2112291526.USD","LU0079474960.USD","SGXZ81514606.USD","LU0122379950.USD","IE00BKDWB100.SGD","SG9999014898.SGD","LU0432979614.USD","LU0210536198.USD","LU0820561909.HKD","LU0203202063.USD","LU0672654240.SGD","LU2028103732.USD","LU0353189763.USD","LU2089284900.SGD","BK4533","LU2237443465.HKD","LU2237443382.USD","LU2108987350.USD","LU0787776722.HKD","LU0289739699.SGD","LU1291159041.SGD","BK4599","LU0234572021.USD","LU2417539215.USD","LU2023250504.SGD","LU2213496289.HKD","LU0256863811.USD","LU1720051108.HKD","LU0708995401.HKD","LU0640476718.USD","SG9999014906.USD","LU2168564222.USD","LU2168564065.EUR","LU0964807845.USD","LU1232071149.USD","LU1988902786.USD","IE0004445239.USD","IE00BK4W5M84.HKD","ELIL","LU0823416689.USD","LU2552382215.SGD","LU2168563687.JPY","LU1093756168.USD","LU2552382058.USD","LU0689472784.USD","LU2471134523.USD","LU0456855351.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU1267930730.SGD","LU1868837136.USD","LU2357305700.SGD","LU0266013472.USD","LU2361044865.SGD","LU2552382132.HKD","LU1917777945.USD","IE00BJLML261.HKD","LU1989771016.USD","LU1868836591.USD","LU1712237335.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU2168564149.EUR","LU2360106947.USD","SGXZ57979304.SGD","SG9999001176.USD","BK4581","IE00BJT1NW94.SGD","NVOH","LU2271345857.HKD","BK4534","LU1814569148.SGD","LU2168564495.EUR","LU2361044949.HKD","IE00B775H168.HKD","LU0320765992.SGD","IE00BN29S564.USD","LLII","LU0225283273.USD","SG9999001176.SGD","LU0889565916.HKD"],"gpt_icon":1},{"id":"2614435038","title":"Novo Nordisk, Vivtex Collaborate on Oral Biologics for Obesity, Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2614435038","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614435038?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:05","pubTimestamp":1772028330,"startTime":"0","endTime":"0","summary":"Novo Nordisk  has entered into a partnership with Vivtex to develop oral biologics for obesity, diabetes and related conditions using Vivtex's drug delivery technologies, the companies said Wednesday.Under the agreement, Vivtex is entitled to receive up to $2.1 billion in upfront payment, research funding, and milestone payments, as well as royalties on future product sales, according to a statement.Vivtex will license certain technologies to Novo Nordisk, which will global development, regulatory, manufacturing and commercialization activities, the companies said.Shares of Novo Nordisk were down 2% in recent premarket activity Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","LU1093756325.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU1093756168.USD","LU0154236417.USD","BK7104","BK4599","NVO","NVOX","BK4588","BK4007","BK4585","NVOH"],"gpt_icon":1},{"id":"1158324592","title":"Novo Nordisk Invests Up to $2.1 Billion in Partnership with Vivtex to Advance Next-Generation Oral Weight-Loss Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=1158324592","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158324592?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:51","pubTimestamp":1772027483,"startTime":"0","endTime":"0","summary":"Danish pharmaceutical company Novo Nordisk announced on Wednesday that it has entered into a collaboration agreement worth up to $2.1 billion with U.S.-based Vivtex to jointly develop next-generation...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU1093756325.SGD","BK4007","NVOX","NVOH","BK4532","IE00BZ1G4Q59.USD","BK4585","LU0154236417.USD","NVO","LU1093756168.USD","IE00BKVL7J92.USD","BK4588"],"gpt_icon":1},{"id":"2614729661","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2614729661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614729661?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:43","pubTimestamp":1771972980,"startTime":"0","endTime":"0","summary":"Blue Owl Capital             OWL    65,787,061     10.73     0.29      2.78. Hims & Hers Health          HIMS    63,794,531     15.46    -0.05     -0.32. Bank of America              BAC    53,050,945     50.41    -0.66     -1.29. Nu Holdings Cl A              NU    49,687,066     16.53     0.34      2.10. Novo Nordisk ADR             NVO    43,800,414     38.59    -1.04     -2.62. Itau Unibanco ADR           ITUB    29,765,557      9.33     0.16      1.74. Petroleo Brasileiro ADR      PBR    26,646,509     16.54     0.40      2.48","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PATX","LU1880398471.USD","LU2129689605.HKD","BAC","LU0154236417.USD","LU0683600562.USD","LU1093756168.USD","PATH","BK4551","LU0234572021.USD","NVOH","LU1506573853.SGD","NVOX","LU1883839398.USD","BK4547","IE00B19Z3581.USD","LU1861558580.USD","LU2129689431.USD","LU0289739699.SGD","NYSE","BK4553","BK4592","LU2133065610.SGD","LU1668664300.SGD","IE00BBT3K403.USD","LU1035773651.USD","LU1201861249.SGD","LU1162221912.USD","BK4007","IE0034235188.USD","LU0314106906.USD","BK4604","LU2265009873.SGD","SG9999013999.USD","BK4588","BK4504","LU0985481810.HKD","LU1496350171.SGD","SG9999001176.SGD","LU0128525689.USD","LU0321505868.SGD","LU1280957306.USD","LU1861559042.SGD","SGXZ57979304.SGD","LU1363072403.SGD","BK4539","LU0320765489.SGD","PFE","BK4568"],"gpt_icon":1},{"id":"2614749697","title":"Novo Nordisk price target lowered to DKK 270 from DKK 340 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2614749697","media":"TIPRANKS","labels":["rating"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614749697?lang=en_us&edition=fundamental","pubTime":"2026-02-25 01:10","pubTimestamp":1771953052,"startTime":"0","endTime":"0","summary":"Barclays lowered the firm’s price target on Novo Nordisk (NVO) to DKK 270 from DKK 340 and keeps an Equal Weight rating on the shares. Published fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-lowered-to-dkk-270-from-dkk-340-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-lowered-to-dkk-270-from-dkk-340-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU1093756325.SGD","BK4007","NVOX","NVOH","BK4532","IE00BZ1G4Q59.USD","BK4585","LU0154236417.USD","NVO","LU1093756168.USD","IE00BKVL7J92.USD","BK4588"],"gpt_icon":0},{"id":"2614462767","title":"Novo Nordisk A/S Stock Falls Tuesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2614462767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614462767?lang=en_us&edition=fundamental","pubTime":"2026-02-25 01:02","pubTimestamp":1771952520,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slid 3.1% to DKK243.65 Tuesday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 0.1% to 2,605.90.This was the stock's fourth consecutive day of losses.The company closed DKK431.55 below its 52-week high of DKK675.20, which the company achieved on February 25, 2025.Trading volume was 22,654,202, compared to the 50-day average trading volume of 8,470,821.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","NVO","BK4585","BK4588","LU1093756168.USD","IE00BZ1G4Q59.USD","NVOH","IE00BKVL7J92.USD","LU1093756325.SGD","NVOX","BK4532","BK4599","BK4007"],"gpt_icon":1},{"id":"2614745647","title":"European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2614745647","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614745647?lang=en_us&edition=fundamental","pubTime":"2026-02-25 00:03","pubTimestamp":1771948999,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Tuesday morning, edging 0.01% higher to 1,839.63 on the S&P Europe Select ADR Index.From continental Europe,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVOH","TRIB","LU1093756325.SGD","AKTX","BK7142","IE00BFMHRM44.USD","LU1093756168.USD","IE00BMPRXN33.USD","TELFY","DBVT","AUTL","LU0006061336.USD","LYG","LNOK","IE00BKVL7J92.USD","NOK","BK4075","BK4007","BK4521","BK4009","IE00BFXG1179.USD","BK4588","IE00BMPRXR70.SGD","SNY","BK4532","BDRX","LU0154236417.USD","BK4207","BK4505","BK4107","MREO","EVAX","BK4115","LU2543165471.USD","CRTO","BK4585","BTI","IE00BZ1G4Q59.USD","SAN","BK7062","NVOX","BK4082","BK4547","NCNA","BK4020","BK4117","BK4139","BK4599","BK7104","NVO"],"gpt_icon":1},{"id":"2614745527","title":"BofA sees limited impact to Eli Lilly’s franchise from Novo’s GLP-1 price update","url":"https://stock-news.laohu8.com/highlight/detail?id=2614745527","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614745527?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:41","pubTimestamp":1771947661,"startTime":"0","endTime":"0","summary":"BofA says that today’s announcement that Novo Nordisk (NVO) plans to slash GLP-1 list prices offers a flashy headline, but in the firm’s view the u...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bofa-sees-limited-impact-to-eli-lillys-franchise-from-novos-glp-1-price-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bofa-sees-limited-impact-to-eli-lillys-franchise-from-novos-glp-1-price-update-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2552382058.USD","NVOH","LU2106854487.HKD","LU2756315664.SGD","LU2357305700.SGD","LU0353189763.USD","LU0225283273.USD","LU2491049909.HKD","SG9999014906.USD","LLYZ","LU0417517546.SGD","LU1868836591.USD","IE00BKVL7J92.USD","LU0354030438.USD","LU0432979614.USD","LU0471298777.SGD","LU2111349929.HKD","GB00BDT5M118.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","IE00BFSS8Q28.SGD","LU0466842654.USD","LU1232071149.USD","SG9999014898.SGD","LU1712237335.SGD","BK4516","SG9999015986.USD","IE00BFSS7M15.SGD","SG9999015952.SGD","LU0158827948.USD","LU0787776722.HKD","IE0005OL40V9.USD","SG9999001176.USD","LU1551013342.USD","LU1291159041.SGD","LU2237443895.HKD","LU0640476718.USD","LU1989771016.USD","BK4585","LU2213496289.HKD","SG9999018857.SGD","ELIS","LU1814569148.SGD","LU0203201768.USD","BK4581","LU1548497426.USD","LU1974910355.USD","LU2168564495.EUR","IE00BN29S564.USD","LU2089283258.USD","LU1868836914.USD","LU0689472784.USD","LU0882574139.USD","SGXZ81514606.USD","IE00BKDWB100.SGD","LU2237443382.USD","LU2756315318.SGD","IE0001KFT4U8.USD","NVO","IE00B4JS1V06.HKD","LU2552382215.SGD","IE00BJJMRZ35.SGD","LU2324357040.USD","LU2271345857.HKD","LU2750360641.GBP","SG9999015978.USD","LU2237443622.USD","LU0006306889.USD","LU1093756168.USD","LU0256863811.USD","IE0009355771.USD","SG9999014880.SGD","LU1720051108.HKD","LU0109391861.USD","LU1267930730.SGD","LU2264538146.SGD","IE00BJJMRX11.SGD","IE00B7KXQ091.USD","LU2491050154.USD","LU0456855351.SGD","LU2237438978.USD","LU0061475181.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4007","LU1366192091.USD","LU1804176565.USD","LU1868836757.USD","LU1145028129.USD","LU0154236417.USD","LU2896262040.SGD","LU2236285917.USD","LU0256863902.USD","LU2360106947.USD","IE00B1XK9C88.USD","LU0385154629.USD","LU1868837300.USD","LU0943347566.SGD","LU2750360997.AUD","IE00BZ1G4Q59.USD","LU2168563687.JPY","LU1623119135.USD","LU0823434583.USD","NVOX","LU2265009873.SGD","LU2491050071.SGD","SG9999001176.SGD","LU2602419157.SGD","LU2089284900.SGD","LU2089984988.USD","BK4599","LU0198837287.USD","LU0889565916.HKD","SG9999014914.USD","LU0323591593.USD","LU0106261372.USD","SG9999018865.SGD","LU1093756325.SGD","LU1064131342.USD","LU0058720904.USD","LU0114720955.EUR","LU1983299246.USD","LU2211815571.USD","BK4590","IE00BFTCPJ56.SGD","LU0820561818.USD","LU2168564149.EUR","LU2471134523.USD","LU2462157665.USD","BK4533","LU0203202063.USD","LLYX","LU1035775433.USD","LU1720051017.SGD","LU2456880835.USD","LU0122379950.USD","LU0820561909.HKD","LU0823434740.USD","LU2023250330.USD","LU2108987350.USD","LU2417539215.USD","LU2471134952.CNY","SG9999015945.SGD","SGXZ31699556.SGD","LU0238689110.USD","LU0823416689.USD","SGXZ99366536.SGD","BK4588","BK4532","LU2237443549.SGD","IE00BJLML261.HKD","LU0109394709.USD","LU0320765059.SGD","LU0094547139.USD","LU2471134879.HKD","LU0882574055.USD","LU0708995401.HKD","LU0289739699.SGD","LU1127390331.HKD","IE00BJJMRY28.SGD","LU0964807845.USD","SG9999013999.USD","LU2361045086.USD","LU0320765992.SGD","IE00BKPKM429.USD","LU1323610961.USD","LU1551013425.SGD","LU0210536198.USD","LU2361044949.HKD","LU2087625088.SGD","LU2552382132.HKD","ELIL","LU0096364046.USD","LU0158827781.USD","LU2023250504.SGD","SG9999017495.SGD","LU2361044865.SGD","IE0004445015.USD","LU1069344957.HKD","LU2746668974.SGD","LU0683600562.USD","LU0234572021.USD","LU1061106388.HKD","IE00BK4W5L77.USD","LU0786609619.USD","LU2237443978.SGD","IE00BK4W5M84.HKD","LU0820562030.AUD","LU1629891620.HKD","LU0316494557.USD","LU2112291526.USD","LU1280957306.USD","BK4534","IE0004445239.USD","LU2468319806.SGD","LU2168564222.USD","LU0353189680.USD","LU0354030511.USD","LU0266013472.USD","LLII","LU0672654240.SGD","LU1988902786.USD","IE00B1BXHZ80.USD","LU2028103732.USD","LU1868837136.USD","LU1917777945.USD","BK4144","IE00BWXC8680.SGD","IE0002141913.USD","LU0471298694.HKD","LU1023059063.AUD","IE00B775H168.HKD","LU2063271972.USD","LU0097036916.USD","LU2471134796.USD","LU2023251221.USD","LU2461242641.AUD","LLY","LU0079474960.USD","LU2168564065.EUR","LU2237443465.HKD","LU2746668461.USD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"1138243470","title":"Eli Lilly Shares Dip Over 1.5% in Premarket Trading Following Rival Novo Nordisk's GLP-1 Drug Price Reduction Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1138243470","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138243470?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:30","pubTimestamp":1771943432,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY.US) shares declined in premarket trading on Tuesday. At the time of writing, the stock was down more than 1.5%, trading at $1,042.5. The movement follows news that its main competitor,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0203202063.USD","LU1868837136.USD","LU1280957306.USD","LU2112291526.USD","LU0256863902.USD","LU0786609619.USD","LU2237438978.USD","LU2491050154.USD","BK4599","IE00B1BXHZ80.USD","LU1868836591.USD","LU0094547139.USD","LU1551013425.SGD","LU2236285917.USD","IE00BZ1G4Q59.USD","BK4535","LU0683600562.USD","LU2063271972.USD","IE0004445239.USD","SGXZ51526630.SGD","LU2462157665.USD","BK4007","LU0203201768.USD","ELIS","IE00B7KXQ091.USD","IE00BKDWB100.SGD","LU0198837287.USD","LU2023251221.USD","LU0158827948.USD","LU2361044949.HKD","LU2108987350.USD","SG9999014898.SGD","BK4534","LU1804176565.USD","LLYZ","TZA","LU1629891620.HKD","LU0096364046.USD","LU2552382215.SGD","LU1868836757.USD","LU1983299246.USD","LU2237443382.USD","LU0225283273.USD","SG9999001176.USD","LU2213496289.HKD","LU2324357040.USD","LU1868836914.USD","LU0964807845.USD","LU0154236417.USD","IE0002141913.USD","SG9999018857.SGD","LU2237443895.HKD","LU1323610961.USD","TWM","IE00B2B36J28.USD","LU0417517546.SGD","LU2552382058.USD","SG9999014914.USD","LU1989771016.USD","LU2750360997.AUD","SGXZ99366536.SGD","LU0114720955.EUR","LU0320765059.SGD","LU0889565916.HKD","LU1023059063.AUD","LU2491050071.SGD","LU0820561909.HKD","IE00BJJMRZ35.SGD","SG9999015986.USD","LLY","SGXZ57979304.SGD","UWM","BK4588","LU1093756168.USD","LU1974910355.USD","LU2360106947.USD","LLYX","GB00BDT5M118.USD","LU1917777945.USD","RWM","SG9999017495.SGD","LU1064131342.USD","IE00BJLML261.HKD","LU0006306889.USD","LU0097036916.USD","LU0266013472.USD","LU2471134523.USD","LU2602419157.SGD","LU1061106388.HKD","LU0353189680.USD","IE00BFSS7M15.SGD","LU1267930730.SGD","LU0708995401.HKD","LU0353189763.USD","NVO","LU0289739699.SGD","LU0820561818.USD","LU1366192091.USD","SG9999018865.SGD","LU2168563687.JPY","LU1232071149.USD","LU0471298777.SGD","LU0466842654.USD","LU1720051108.HKD","BK4516","LU2264538146.SGD","LU1868837300.USD","LU0672654240.SGD","LU2471134952.CNY","LU0316494557.USD","LU2456880835.USD","LU2756315664.SGD","LU1291159041.SGD","SG9999015952.SGD","LU0256863811.USD","BK4550","LU2471134796.USD","LU2265009873.SGD","LU0109391861.USD","LU1035775433.USD","LU2237443549.SGD","LU2417539215.USD","LU1988902786.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU2750360641.GBP","IE00BN29S564.USD","LU0158827781.USD","LU2237443978.SGD","SG9999001176.SGD","LU2746668461.USD","SGXZ31699556.SGD","SG9999015978.USD","BK4144","LU0061475181.USD","LU0432979614.USD","LU0689472784.USD","LU0823434583.USD","IE00BK4W5L77.USD","IE00B4R5TH58.HKD","LLII","LU2023250504.SGD","LU2106854487.HKD","LU0471298694.HKD","LU0823434740.USD","LU0210536198.USD","LU0079474960.USD","LU2168564149.EUR","SGXZ81514606.USD","BK4533","LU2357305700.SGD","LU0943347566.SGD","LU2552382132.HKD","SG9999014906.USD","SG9999015945.SGD","LU0058720904.USD","LU2111349929.HKD","IE0001KFT4U8.USD","LU2237443622.USD","LU0323591593.USD","LU2361044865.SGD","LU0882574055.USD","BK4585","BK4590","LU0109394709.USD","LU1069344957.HKD","LU2089283258.USD","IE00BKPKM429.USD","IE00BKVL7J92.USD","ELIL","LU0122379950.USD","LU2089984988.USD","LU2271345857.HKD","IE00BWXC8680.SGD","LU0456855351.SGD","NVOX","SG9999014880.SGD","BK4532","LU1720051017.SGD","LU1623119135.USD","LU2746668974.SGD","LU2087625088.SGD","IE00B4JS1V06.HKD","LU0787776722.HKD","IWO","LU2471134879.HKD","IE00BK4W5M84.HKD","LU2028103732.USD","IE0004445015.USD","IE00BJJMRX11.SGD","LU0640476718.USD","LU1057294990.SGD","IE00B1XK9C88.USD","LU2896262040.SGD","LU2756315318.SGD","LU0354030511.USD","BK4581","LU0234572021.USD","LU0320765992.SGD","LU0385154629.USD","LU1127390331.HKD","LU1548497426.USD","LU0820562030.AUD","LU1093756325.SGD","LU0238689110.USD","LU1712237335.SGD","SG9999013999.USD","MNQmain","LU0882574139.USD","LU0823416689.USD","IE0009355771.USD","LU1551013342.USD","LU2168564065.EUR","TNA","LU2461242641.AUD","LU0106261372.USD","IE00BFSS8Q28.SGD","LU2491049909.HKD","IWN","LU2089284900.SGD","LU2168564222.USD","SRTY","LU2237443465.HKD","LU1145028129.USD","LU2468319806.SGD","NVOH","LU2211815571.USD","LU1814569148.SGD","IE00B775H168.HKD","LU2168564495.EUR","IE0005OL40V9.USD","IE00BFTCPJ56.SGD","LU2361045086.USD","LU2023250330.USD"],"gpt_icon":1},{"id":"2613717896","title":"Novo Nordisk Stock (NVO) Sinks Further on Wegovy and Ozempic Price-Cut Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2613717896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613717896?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:50","pubTimestamp":1771941028,"startTime":"0","endTime":"0","summary":"After a plunge of more than 16% on Monday following the below-expectation CagriSema trial results, shares in Novo Nordisk ($NVO) continued to slide...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-sinks-further-on-wegovy-and-ozempic-price-cut-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-stock-nvo-sinks-further-on-wegovy-and-ozempic-price-cut-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4585","NVOX","IE00BZ1G4Q59.USD","NVOH","BK4588","NVO","LU1093756325.SGD","IE00BKVL7J92.USD","BK4599","BK4007","LU0154236417.USD","LU1093756168.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":176,"code":"91000000","status":"200"}]}}